Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06870383Active, not recruiting
Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Tanta University. Primary endpoint: Total opioid consumption in first 24 hours after surgery. Started Mar 2025; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06870383.